|
|||||
|
|
A short report on highlights of world-wide development of RIX4414: an European experience |
|
| Authors: | Vesikari T Karvonen A Puustinen L Szakal E D Zeng S-Q Delem A De Vos B |
| Affiliation: | University of Tampere, Medical School/FM3, Vaccine Research Center, University of Tampere, 33014 Tampere, Finland. timo.vesikari@uta.fi |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |